£10bn NHS medtech spend undermined by ‘lack of data’, warns DHSC director

By Jack Serle2024-09-16T12:04:00

The lack of information about the performance and value for money of medtech products is leading to ineffective procurement and wasting scarce NHS funding, a senior government official has told HSJ.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here